Sonoma Pharmaceuticals, Inc.

0.18 USD
-0.01 (-6.78%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sonoma Pharmaceuticals, Inc. stock is up 17.33% since 30 days ago. The next earnings date is Jun 24, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 27.78% of the previous 17 June’s closed higher than May.

About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, a prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses. It also offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites.